Study following adults with skin psoriasis over time
Part of Bones, joints & muscles, Skin clinical trials.
This observational study is looking at adults with skin psoriasis and collecting real-world information about their condition and experiences. It may help researchers better understand psoriasis and how it affects people, without giving a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- You have a self-reported diagnosis of skin psoriasis.
- You are willing and able to read/sign consent and complete study questionnaires in an approved language.
- You have psoriasis but do not have a previously diagnosed psoriatic arthritis (joint disease called PsA).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with psoriasis over time to better understand the condition and how it changes. You may be able to join if your psoriasis started more than 3 years ago and you can agree to take part.
This study tests a smartphone app that measures skin inflammation in people with psoriasis. Researchers want to see if the app can accurately track your condition using your phone's camera and sensors, which could help doctors monitor your disease more easily.
This study tests a new way to screen for psoriatic arthritis (a type of joint inflammation) in people with psoriasis. It looks at a tool called PEST and aims to improve early detection.
This study looks at health problems like heart disease and arthritis that are common in people with psoriasis. It aims to better understand these connections to improve care.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
Hear when a new Psoriatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.